In October, MedeAnalytics is recognizing Breast Cancer Awareness Month, a worldwide campaign to increase awareness, education and research about breast health and the importance of early detection. Breast cancer is the second most common kind of cancer in women, and one in eight women will get breast cancer in their life time. Through annual screenings like mammograms, women can survive breast cancer when it’s found and treated early.
Here’s how MedeAnalytics will recognize Breast Cancer Awareness Month:
- Our associates will be participating as a team, Mede Pirates of The Cure-Ribbean, in the Race for the Cure in Dallas on Saturday, October 26 and remote employees will be joining their local races.
- MedeAnalytics has partnered with Susan G. Komen to present a collaborative Lunch & Learn educational event hosted by Susan G. Komen ambassador Natasha Mmeje. MedeAnalytics’ employees will learn about the latest in breast cancer research and treatment resources.
- Wear Pink Wednesdays will be acknowledged throughout October to drive awareness
- Employees can share their personal stories of their loved ones and friends to show support on our internal message board
Join us as we participate in promoting this important message of hope and support.
Get our take on industry trends
Providers: Are you ready to be audited?
By Donna Kennedy In 2020, regular audits conducted by CMS and other payers were paused or significantly reduced as the…
Read on...From Insights to Action – The Digital Transformation of Healthcare in the Post-Pandemic “New Normal”
In November, MedeAnalytics hosted the 2021 Impact Summit, an engaging and educational event held annually and designed exclusively for our…
Read on...2022 Rx: Your new, post-pandemic prescription for success
By Dave Schweppe, Chief Analytics Officer, MedeAnalytics Despite the common use of the term “post-COVID,” most leaders across the healthcare…
Read on...Combating the opioid epidemic in North America with Nobel Prize winning research
American Researchers Dr. David Julius and Dr. Ardem Patapoutian from California were awarded the Nobel Prize in medicine for their path breaking work on the development of non-opioid painkillers, showing immense promise for combating the epidemic.
Read on...